首頁 › 職業類別 › Biochemists and Biophysicists › Lexington, MA
Lexington, MA 的 Biochemists and Biophysicists：H-1B 薪資
工作地点位於 Lexington, MA 的此職業共計 45 份勞動條件申請。中位數基本薪資為 $125,000；中間半數區間為 $116,254–$140,202。
申請案（LCAs）45
薪資中位數$125,000
薪資中間區間$116,254–$140,202
第10至第90百分位$107,091–$150,623
依薪資等級
| 薪資等級 | 薪資中位數 |
|---|---|
| 等級 I（入門） | $110,000 |
| 等級 II（合格） | $117,754 |
| 等級 III（資深） | $137,605 |
| 等級 IV（完全勝任） | $149,029 |
勞工部為每個職業和地區設定四個現行工資等級，從等級 I（入門）到等級 IV（完全勝任）。雇主選擇符合職位要求的等級。
雇主
| 雇主 | LCAs | 薪資中位數 |
|---|---|---|
| Takeda Development Center Americas, Inc. | 10 | $122,000 |
| Wave Life Sciences USA, Inc. | 4 | $129,135 |
| Novo Nordisk Research & Development US, Inc. | 4 | $131,560 |
| KSQ Therapeutics, Inc. | 3 | $120,000 |
| Valo Health, Inc. | 3 | $135,000 |
| Voyager Therapeutics, Inc. | 3 | $145,000 |
| Cystic Fibrosis Foundation | 2 | $124,050 |
| SalioGen Therapeutics Inc. | 2 | $157,000 |
| VAStek Inc. | 2 | — |
| Genezen MA, Inc. | 2 | $129,000 |
| Accent Therapeutics, Inc. | 1 | $108,420 |
| Kiniksa Pharmaceuticals Corp. | 1 | $98,000 |
| Agenus Inc. | 1 | $82,555 |
| Albert Einstein College of Medicine | 1 | — |
| Shire Human Genetic Therapies Inc. | 1 | $106,012 |
| Alexion Pharmaceuticals, Inc. | 1 | $119,600 |
| Agilent Technologies, Inc. | 1 | $145,927 |
| Fapon Life Sciences Inc. | 1 | $125,000 |
| Dicerna Pharmaceuticals, Inc. | 1 | $107,562 |
| Thermo Fisher Scientific Inc. | 1 | $143,894 |
職位名稱
- Scientist5
- Senior Scientist3
- Senior Scientist, Analytical Development2
- Scientist I2
- Assoc Scientist II - Discovery Research2
- Research Associate Protein Biochemistry2
- Scientist I, Biochemistry1
- Senior Scientist, Lead Discovery (Biochemistry)1
- Scientist, Immunobiology1
- Senior Assoc. Scientist, Bioanalytical & Biomarker Developmt1
- Associate Scientist, Analytical Sciences & Quality Testing1
- Scientist I, ADME1
- Senior Research Associate1
- Research Investigator1
- Staff Scientist1
薪資為每份申請所提供工資的下限，並換算為年度金額；統計數據僅使用經認證的全職申請。LCA 並非簽證批准，且一份 LCA 可涵蓋多個職位。 來源：美國勞工部 OFLC LCA 揭露資料，財政年度 2023–2026（最新決定日期：2026年6月30日）。